Role of CD47 in Hematological Malignancies | Journal of Hematology & Oncology | Full Text
Targeting CD47 for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
Frontiers | Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Anticorps CD47 (BRIC 126) | SCBT - Santa Cruz Biotechnology
Deciphering the role of CD47 in cancer immunotherapy - ScienceDirect
CD47: the next checkpoint target for cancer immunotherapy - ScienceDirect
Integrin-Associated Protein CD47 Leukocyte Surface Antigen
A) CD47-SIRPɑ interaction blocks macrophage phagocytosis of cancer... | Download Scientific Diagram
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells | Nature Communications
CD47 Structure and binding partners. CD47 is a transmembrane protein... | Download Scientific Diagram
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions | bioRxiv
CD47: role in the immune system and application to cancer therapy | Cellular Oncology
Role of CD47 in Hematological Malignancies | Journal of Hematology & Oncology | Full Text
Antiphagocytic function of CD47 on red blood cells (RBCs). Young RBCs... | Download Scientific Diagram
Just eat it: A review of CD47 and SIRP-α antagonism - ScienceDirect
CD47 | Majeti Lab | Stanford Medicine
Targeting the CD47/SIRPɑ Axis in Cancer Immunotherapy
Frontiers | Targeting CD47 as a Novel Immunotherapy for Breast Cancer
Cancers | Free Full-Text | Cancer Therapy Targeting CD47/SIRPα
Frontiers | CD47 as a promising therapeutic target in oncology
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy: Trends in Immunology
CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two) – Creative Biolabs Blog
